相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genes associatedwith diabetes: potential for novel therapeutic targets?
Kazuo Hara et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients
Xueyan Zhou et al.
SCIENTIFIC REPORTS (2016)
Pharmacogenomics of glinides
Miao Chen et al.
PHARMACOGENOMICS (2015)
Comparison of repaglinide and metformin monotherapy as an initial therapy in Chinese patients with newly diagnosed type 2 diabetes mellitus
Fu-Sheng Fang et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Effects of NOS1AP rs12742393 Polymorphism on Repaglinide Response in Chinese Patients with Type 2 Diabetes Mellitus
Tao Wang et al.
PHARMACOTHERAPY (2014)
A Genome-Wide Association Study Identifies GRK5 and RASGRP1 as Type 2 Diabetes Loci in Chinese Hans
Huaixing Li et al.
DIABETES (2013)
GRK5 ablation contributes to insulin resistance
Li Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes
Zhi-Cheng Gong et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese Type 2 diabetic patients
Xing-Ping Dai et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Repaglinide A Review of Its Use in Type 2 Diabetes Mellitus
Lesley J. Scott
DRUGS (2012)
Genetic advances of type 2 diabetes in Chinese populations
Weihui Yu et al.
JOURNAL OF DIABETES (2012)
G Protein-Coupled Receptor Kinase 5 Phosphorylation of Hip Regulates Internalization of the Chemokine Receptor CXCR4
Breann L. Barker et al.
BIOCHEMISTRY (2011)
Effects of KCNQ1 Polymorphisms on the Therapeutic Efficacy of Oral Antidiabetic Drugs in Chinese Patients With Type 2 Diabetes
W. Yu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Globalization of Diabetes The role of diet, lifestyle, and genes
Frank B. Hu
DIABETES CARE (2011)
Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
Dorota Tomalik-Scharte et al.
DRUG METABOLISM AND DISPOSITION (2011)
Dual Mode of glucagon receptor internalization: Role of PKCα, GRKs and β-arrestins
Lada Krilov et al.
EXPERIMENTAL CELL RESEARCH (2011)
IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population
Qiong Huang et al.
ACTA PHARMACOLOGICA SINICA (2010)
A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese
Wen Qin et al.
ACTA PHARMACOLOGICA SINICA (2010)
KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) Polymorphisms Affect Therapeutic Efficacy of Repaglinide in Chinese Patients With Type 2 Diabetes
M. Yu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients
Qiong Huang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Prevalence of Diabetes among Men and Women in China
Wenying Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Insulin Resistance and Hyperinsulinemia Is hyperinsulinemia the cart or the horse?
Michael H. Shanik et al.
DIABETES CARE (2008)
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
Hiroyuki Unoki et al.
NATURE GENETICS (2008)
Phosphorylation of the β2-Adrenergic receptor in plasma membranes by intrinsic GRK5
Tuan M. Tran et al.
BIOCHEMISTRY (2007)
Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients
Lin-yong Xu et al.
ACTA PHARMACOLOGICA SINICA (2007)
Improvement of insulin sensitivity and β-cell function by nateglinide and repaglinide in type 2 diabetic patients -: a randomized controlled double-blind and double-dummy multicentre clinical trial
J. Li et al.
DIABETES OBESITY & METABOLISM (2007)
A genome-wide association study identifies novel risk loci for type 2 diabetes
Robert Sladek et al.
NATURE (2007)
Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFκB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages
Narayanan Parameswaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Repaglinide versus nateglinide monotherapy - A randomized multicenter study
J Rosenstock et al.
DIABETES CARE (2004)
A family with severe insulin resistance and diabetes due to a mutation in AKT2
S George et al.
SCIENCE (2004)
CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide
TB Bidstrup et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Differential selectivity of insulin secretagogues - Mechanisms, clinical implications, and drug interactions
FM Gribble et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)
H Cho et al.
SCIENCE (2001)
分享论文
